We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
FMWA
926
Forvis Mazars Wealth Advisors
Missouri
$3.02M +$487K +1,039 +19%
SCCM
927
Schafer Cullen Capital Management
New York
$3M -$2.82M -6,004 -48%
BPCA
928
Bank Pictet & Cie (Asia)
Singapore
$2.99M +$22K +47 +0.7%
OCM
929
Orleans Capital Management
Louisiana
$2.98M -$25.8K -55 -0.9%
GI
930
GS Investments
Minnesota
$2.96M +$2.98M +6,363 New
BWM
931
BNC Wealth Management
Oregon
$2.95M +$16.4K +35 +0.6%
GCC
932
Guardian Capital (Canada)
Ontario, Canada
$2.94M +$68K +145 +2%
AA
933
Altman Advisors
Illinois
$2.93M -$12.7K -27 -0.4%
HTHT
934
Hemenway Trust Hemenway Trust
New Hampshire
$2.88M +$3.28K +7 +0.1%
FHA
935
Flagship Harbor Advisors
Massachusetts
$2.88M +$207K +442 +8%
HPCM
936
Hunter Perkins Capital Management
Illinois
$2.84M +$516K +1,100 +22%
BOH
937
Bank of Hawaii
Hawaii
$2.83M -$988K -2,107 -26%
SBL
938
Sargent Bickham Lagudis
Colorado
$2.82M +$150K +320 +6%
CIP
939
Cornerstone Investment Partners
Georgia
$2.82M -$23.4K -50 -0.8%
BIAS
940
Beacon Investment Advisory Services
New Jersey
$2.82M +$362K +771 +15%
ST
941
Smithfield Trust
Pennsylvania
$2.8M -$281K -600 -9%
NSEDCP
942
NJ State Employees Deferred Compensation Plan
New Jersey
$2.79M
AS
943
Altshuler Shaham
Israel
$2.79M +$724K +1,544 +35%
KP
944
Keel Point
Alabama
$2.79M +$262K +559 +10%
IAA
945
Independent Advisor Alliance
North Carolina
$2.78M +$46.4K +99 +2%
ANRIA
946
American National Registered Investment Advisor
Texas
$2.77M
MF
947
Magnetar Financial
Illinois
$2.77M +$2.79M +5,941 New
WIC
948
WealthBridge Investment Counsel
Alberta, Canada
$2.75M +$202K +430 +8%
AAS
949
Avantax Advisory Services
Texas
$2.73M -$1.47M -3,128 -35%
CCP
950
Corient Capital Partners
California
$2.73M -$1.2M -2,551 -30%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.